Needham Downgrades Biogen (BIIB) to Hold, 'Expert Checks Suggest Slow Leqembi Ramp; Limited 2025 Catalysts'
Tweet Send to a Friend
(Updated - November 18, 2024 8:47 AM EST)
Needham analyst Ami Fadia downgraded Biogen (NASDAQ: BIIB) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham analyst Ami Fadia downgraded Biogen (NASDAQ: BIIB) from Buy to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
